Category Biodiversity/Genetic Resources/Biotech

EU High Court Bans Patents On Human Embryo Stem Cells For Commerce

The European Union high court today outlawed the patenting of human embryo stem cells for scientific research or commercial purposes. The decision has forced European courts to examine the “ethical boundaries of patenting,” said Greenpeace, which challenged a German patent in the case. While there are alternate methods for obtaining stem cells, the ruling will nevertheless affect some research, one patent lawyer said.

With WTO Stalled, GI Industry Proponents Move To Create Their Own Register

An international private-sector network lobbying for the protection of geographical indications is set to establish a compilation of all GIs currently protected in the world in what could seem like a response to the repeated failure of governments to agree on the establishment of a GIs register at the World Trade Organization. The Organization for an International Geographical Indications Network (OriGIn), meeting for its fifth General Assembly, also voiced concerns about the lack of protection of GIs in cyberspace.

Experts Still Divided On Influence Of IP On Biodiversity Conservation

While the global loss of biodiversity is widely recognised, the question of whether the influence of intellectual property rights on the protection of biodiversity is positive or negative does not achieve such consensus. A discussion among specialists on 14 September showed that clear evidence is lacking about the impact of IP rights. Some said the IP system as it stands might be ill-fitted to answer the needs of this particular field.

South Africa Conference On IP And Innovation

A conference being held in South Africa this week will address the sensitive topic of intellectual property and innovation in the developing country context. On hand will be a top team of developed country experts with a mix of Indian and Chinese specialists.

Myriad Outcome: Winds Shift Again For Gene Patenting In The US

In a long-awaited decision, a United States federal appeals court has decided that US companies can patent breast cancer genes, reversing a previous ruling. The decision was not unanimous, with one of the three judges dissenting. But despite the attention the case has received, the ruling may have little impact on the biotechnology industry, according to analysts.

Extension Of WIPO Committee On TK, Genetic Resources Appears Likely

As the mandate of the World Intellectual Property committee on the protection of genetic resources, traditional knowledge, and folklore is reaching its end, diplomats meeting this week seem to be coming to agreement on its extension. Meanwhile, a group of developing countries submitted proposals for each of the three legs of the committee, to be considered as delegates go through draft negotiating texts produced at the last session of the committee.

Kenya Opens Region’s Door To GM Maize

In the face of a severe food shortage, Kenya's Cabinet has approved imports of genetically modified maize, though it has drawn the line on use of GM maize as seeds, a regional newspaper reports.